What Бесалол Treats: Main Uses and Benefits

Бесалол is commonly used across conditions presenting with acute episodes that involve symptoms related to physical discomfort and symptoms of increased neurological or muscular activity in the gastrointestinal (GI) tract. The medicine is a fixed-dose combination, and its two active components are commonly used to help with symptomatic support during phases when symptoms become more noticeable.

One component, belladonna alkaloids, may assist with easing the disruptive symptoms of GI spasms and cramping. The anticholinergic/antispasmodic action provided by this class of ingredients is applied as adjunctive therapy in conditions such as irritable bowel syndrome (IBS) and acute enterocolitis.

The second active ingredient, phenazone (antipyrine), is considered relevant for easing symptoms related to physical discomfort. The combination provides support that helps ease the overall symptom burden and plays a role in managing symptoms that interfere with daily comfort. The combined effect supports the patient during difficult episodes by easing distress and may assist with maintaining functional stability when symptoms interfere with routine activities.

---

Quick Fact: Relevant for Easing Spasmodic GI Discomfort

Regulatory References

1. DailyMed drug label overview for Belladonna Alkaloids

The eligibility for using Бесалол is strictly defined by official regulatory documents, primarily due to the restrictions associated with its anticholinergic component. Use is generally permitted for Adults and Adolescents when no contraindications are present, but older adults must use the medicine with caution.

Contraindicated Populations

Use is contraindicated and must be avoided in patients with conditions that could be severely worsened by anticholinergic action. These include Closed-Angle Glaucoma, Obstructive Uropathy (e.g., prostatic hypertrophy), Obstructive Disease of the Gastrointestinal Tract (e.g., paralytic ileus), Severe Ulcerative Colitis with risk of toxic megacolon, and Myasthenia Gravis.

Age and Physiological Restrictions

The medicine is generally not recommended or contraindicated in the pediatric population (e.g., children under 18 years) as safety and efficacy have not been established. Use is contraindicated during pregnancy, and breastfeeding should be discontinued if the medicine is necessary during lactation. Furthermore, patients with hepatic or renal disease and those with pre-existing cardiac conditions (e.g., tachycardia, arrhythmias) require caution and close supervision.

Interactions with other medicines and products

The official interaction profile for Бесалол is defined by the additive effects of its Belladonna alkaloid component and the exposure modifications related to its salicylate metabolite.

Pharmacodynamic and Additive Effects

Co-administration with other Anticholinergic Agents (such as certain tricyclic antidepressants or antihistamines) is documented to result in additive anticholinergic effects. Similarly, combining Бесалол with Alcohol (Ethanol) or other Central Nervous System (CNS) Depressants (e.g., sedatives or narcotics) is officially noted to produce additive CNS depressant effects.

Exposure Modification and Timing Rules

The anticholinergic action of Бесалол, which slows gastrointestinal transit, necessitates mandatory time separation for several products. Administration must be separated from Antacids/Antidiarrheal Agents and Ketoconazole to prevent interference with absorption. The slowed motility may also lead to increased serum concentrations of products like slow-dissolving Digoxin.

The salicylate metabolite of Бесалол is documented to interact with other medications by affecting clearance and response. The co-administration may enhance the effect of Anticoagulants (such as Warfarin) and Oral Hypoglycemic Agents. Furthermore, the salicylate component is documented to reduce the renal clearance of Methotrexate, leading to increased exposure of that medicine.

How Бесалол Works

The mechanism of action of Бесалол is based on the combined effects of its two distinct components, which target both the neural control and the mucosal lining of the gastrointestinal system.

---

Localized Mucosal Protection and Astringency

The bismuth subnitrate component exerts a physicochemical mechanism directly on the gut lining. It reacts locally to form insoluble precipitates and a protective colloidal barrier over mucosal surfaces. This barrier provides a physical layer over the underlying tissue, limiting contact with gastric acid and digestive fluids. Additionally, the compound possesses an astringent property, which contributes to local tissue firming.

---

Antispasmodic Blockade of Cholinergic Signaling

The belladonna extract contains anticholinergic alkaloids that act as competitive antagonists at the muscarinic acetylcholine receptors ( mAChRs) in the smooth muscles and glands of the digestive tract. By blocking the binding of the neurotransmitter acetylcholine, this mechanism dampens excitatory neural signaling within the parasympathetic pathway. The resulting physiological effect is the relaxation of gastrointestinal smooth muscles (antispasmodic effect) and a reduction in glandular secretion, resulting from the cessation of excitatory cholinergic input.

How to Use Бесалол

The usage of Бесалол, a fixed-combination oral tablet containing Belladonna Folia Extract (10 mg) and Phenylsalicylate (300 mg), follows a defined set of instructions.

The established and exclusive route of administration is oral ingestion. The medication is dosed according to a precise schedule: the standard single dose is defined as one tablet, which is typically administered two to three times per day (divided daily use). It is an essential instruction that the total daily intake must not exceed the maximum daily dose of six tablets.

---

The administration schedule is subject to a strict time-bound constraint: the course of treatment is limited to a maximum duration of seven days, which defines the drug's profile for short-term symptomatic support. The use of Бесалол is restricted to the adult population; it is not indicated for administration in individuals under 18 years of age.

Due to the nature of the active components, a procedural constraint is noted: users must exercise caution when performing tasks that require increased visual acuity or high levels of concentration. The ultimate dosage and duration, though constrained by the established limits, are determined individually.

Research Evidence / Overview of Studies for Бесалол

---

Evidence for Symptomatic Relief of Acute Gastrointestinal Spasms and Colicky Pain

Evidence related to the primary action of Бесалол's Belladonna component—an antispasmodic—is derived mainly from systematic reviews and meta-analyses. These studies examine the therapeutic class in the context of functional gastrointestinal disorders, such as Irritable Bowel Syndrome (IBS), in adult populations. Researchers explored short-term changes, tracking patient-reported measurements of abdominal pain intensity and overall global symptom status. Findings from these class studies describe patterns observed during defined treatment intervals.

The Dual-Component Research Structure

As a fixed-combination medicine, the research base reflects the two distinct actions of its ingredients. The majority of formal evidence is directed toward the antispasmodic action. The second component, Phenylsalicylate, which releases compounds with a mild antiseptic action, was studied in contexts involving localized gut environments. However, dedicated research describing the combined contribution of both the spasm relief and the mild antiseptic action to total short-term symptomatic support remains limited.

Duration and Limitations of Current Research

The research exploring symptom changes typically involved follow-up durations that were limited, with observation periods for the antispasmodic class generally ranging from one to twelve weeks. Consequently, information for long-term outcomes is not fully established for the Belladonna component or the fixed combination.

A major limitation is the lack of modern, dedicated Randomized Controlled Trials (RCTs) that specifically examined the precise fixed-dose combination of Belladonna Folia Extract and Phenylsalicylate. Furthermore, data for certain patient groups, including older adults or those with multiple health conditions, remains insufficient, and subgroup findings are uncertain.

Key Studies & References

1. Belladonna Alkaloids DailyMed Drug Label Overview (for Antispasmodic Class Use)

Common questions about Бесалол (FAQ)

---

Q: How long does it take for Бесалол to start working?

Official prescribing documents do not state a precise timeframe for the onset of action. The effect is related to the medicine's anticholinergic component, which acts after being absorbed.

Q: Does Бесалол treat the condition or only relieve the symptoms?

According to the official product information, Бесалол is indicated for the short-term symptomatic relief of spasms and associated discomfort. It is designed to alleviate the experienced pain and contractions, but is not designated as a curative medicine for the underlying cause of the condition.

Q: Is Бесалол safe for older adults?

Official prescribing information indicates that older adults may exhibit increased sensitivity to the anticholinergic effects of the medicine. Due to this potential for sensitivity, official product information suggests that use in older adults may require supervision.

Q: Why is caution advised for individuals with kidney or liver problems?

Official documentation notes that caution is required for individuals with hepatic (liver) or renal (kidney) disease. This is because the body relies on these organs to eliminate and metabolize the drug's components, and impaired function may alter how the drug is handled by the body.

Q: Why is it important not to exceed the recommended duration of the Бесалол course?

The authorized course of treatment is limited to a short period, typically a maximum of seven days. This duration is specified because the medicine is intended for short-term symptomatic use, and safety data concerning effects from prolonged, long-term use are not well-established.

Q: Is Бесалол an antibiotic or something else?

Бесалол is classified as a combination antispasmodic and antiseptic agent. The medicine works to relax the smooth muscles of the gastrointestinal tract and provide local antiseptic action in the gut. Official documents do not classify the medicine as an antibiotic.

Q: Is Бесалол prescription or over-the-counter?

The dispensing status of Бесалол is determined by local regulatory authorities and defines whether it is an over-the-counter (OTC) or prescription-only medicine. The legal dispensing status depends on the specific rules of the local health authority.

Q: What should be done if a dose of Бесалол is missed?

Official prescribing documents provide specific, non-directive instructions on the procedure to follow in the event of a missed dose. The product information contains the authorized guidance for continuing treatment after a missed dose.

Q: Is there a risk of dependence or addiction associated with Бесалол?

Official regulatory documents do not contain warnings or contraindications related to the potential for dependence, abuse, or addiction. This is noted when the medicine is used strictly according to the prescribed short-term regimen.

Q: How is Бесалол different from other popular stomach medicines?

Бесалол is distinguished by its dual mechanism of action. It combines the smooth muscle relaxation provided by its antispasmodic component with a mild localized antiseptic action in the gut lumen. This dual approach addresses both muscular tension and the internal gut environment.

Q: Can Бесалол be taken if I have an allergy to other medicines?

The medicine is formally contraindicated (should not be used) in individuals who have a known hypersensitivity or allergic reaction to any of its active substances or inactive ingredients (excipients). Official documentation stresses the importance of avoiding the medicine in cases of known allergy to its components.

Q: Where can I find official information about Бесалол from health authorities?

Official, authoritative information about the medicine is maintained by national and intergovernmental regulatory bodies. These include sources such as the FDA DailyMed in the US, the European Medicines Agency (EMA), and other national health authority drug profile databases. These official records contain the definitive regulatory status and warnings.

Q: Can Бесалол be taken if planning pregnancy?

Official documents state that use is contraindicated during pregnancy. If planning pregnancy, it is important to seek guidance from a qualified health professional, as use is contraindicated during pregnancy.

Q: Are there mandatory time restrictions for taking Бесалол (morning or evening)?

The medicine is prescribed to be taken at divided intervals, typically two to three times per day. Official documents do not specify mandatory restrictions or instructions regarding the time of day (such as morning or evening) for administration.

Q: Why do the instructions specify the relation of dosing to meals (if applicable)?

Official prescribing instructions specify the medicine's relationship to food (such as before, with, or after a meal). This guidance is given to ensure optimal absorption and effectiveness of the active ingredients within the digestive tract.

Q: What popular over-the-counter (OTC) medicines can Бесалол interact with?

Official documents describe interactions with several popular over-the-counter medicines, including antacids and agents that may also have CNS depressant effects. Interactions are also noted for products like oral hypoglycemic agents and agents that affect blood clotting.

Q: How can Бесалол affect blood test results?

Official documentation may describe how the salicylate component of the medicine can interfere with the results of certain laboratory tests. These potential interferences can involve tests that measure clotting time or specific metabolites, and caution is advised if undergoing lab work.

Q: Can Бесалол be used for prevention?

The medicine's officially approved indications are strictly for the therapeutic relief of existing spasms and pain. It is not described in official documents as being indicated for prophylactic (preventive) use against future symptoms.

Q: Does Бесалол affect blood pressure?

Official documents list tachycardia (increased heart rate) as an officially recognized adverse reaction. However, a documented effect on arterial blood pressure is not routinely listed in the common adverse reaction sections of the prescribing information.

Q: What is meant by 'individual intolerance' to Бесалол components?

The term individual intolerance typically refers to the experience of unpleasant symptoms or adverse effects that are not necessarily allergic in nature. These effects require the patient to discontinue the medicine and are usually listed among the potential adverse reactions.

Q: What warnings are listed in the official instructions for Бесалол?

Official prescribing information contains a list of mandatory warnings and precautions. These include the documented risk of Acute Angle-Closure Glaucoma, caution regarding the risk of Heat Prostration in high temperatures, and includes special precautions for patients with pre-existing cardiac conditions.

Q: Where can official information about Бесалол clinical trials be found?

Official information regarding clinical trials is typically housed in government-sponsored trial registries. Users can find trial summaries or links to data through databases such as the NIH ClinicalTrials.gov or equivalent national and international systems that track pharmaceutical research.

Q: Do I need to stop taking other medicines when starting Бесалол?

Official documents describe specific interactions where dose modification or separation of administration time is authorized for co-administered drugs. This includes medicines like antacids or antidiarrheal agents.

Q: Can Бесалол cause mood changes or anxiety?

Documented adverse effects are primarily related to the central nervous system, such as headache, dizziness, and drowsiness. Alterations in mood or anxiety are generally not listed as common side effects in the official sources.

Q: Can Бесалол help with heartburn?

The medicine is officially indicated for the relief of spasms and pain. While its mechanism of action involves a reduction of glandular secretion, it is not listed as an approved therapeutic indication specifically for treating heartburn.

Q: Is there a risk of Бесалол overdose?

The official prescribing information provides detailed documentation regarding the potential symptoms and risks associated with an overdose of the medicine. This information includes general guidance on overdose management.

Q: Is it true that Бесалол can affect blood sugar levels?

The medicine is documented to interact with oral hypoglycemic agents (drugs used to control blood sugar). The documented interaction with oral hypoglycemic agents indicates that blood glucose control may be affected.

Q: What does the 'antispasmodic' action of Бесалол mean?

The term antispasmodic action refers to the medicine's documented effect of inducing relaxation of the smooth muscles in the gastrointestinal tract. This action is designed to alleviate internal involuntary contractions (spasms) that cause pain.

Storage and Protection Requirements

Condition	Requirement
Storage Temperature	The tablets must be stored at a refrigerated temperature, specifically between 2 C and 8 C.
Shelf-Life	The official expiration date of 4 years is guaranteed only when the product is stored consistently within the required temperature range.
Protection	The medicine must be kept in its original packaging to protect the tablets from environmental factors such as light and moisture.

Child Safety and Disposal

For safety, Бесалол must be stored out of the sight and reach of children at all times.

Disposal of any expired or unused tablets should follow official guidelines. The preferred method is to utilize a drug take-back program or an authorized collection kiosk. If these options are not readily available, the tablets may be disposed of in household trash after being mixed with an unappealing substance, such as dirt or used coffee grounds, sealed in a bag, and then discarded.